Description
Chlamydia Trachomatis, Neisseria Gonorrhea, Herpes Simplex Virus 1, Herpes Simplex Virus 2, Haemophilus Ducreyi, Mycoplasma Genitalium,Mycoplasma Hominis, Treponema Pallidum,Ureaplasma Parvum, Ureaplasma Urealyticum
Sample Type:Early Morning Urine
Tests Included:
A comprehensive panel of tests for various sexually transmitted infections (STIs), including Chlamydia, Gonorrhea, Syphilis, Herpes Simplex Virus 1 and 2 (HSV-1 and HSV-2), Human Immunodeficiency Virus (HIV), Hepatitis B and C, Trichomoniasis, Mycoplasma genitalium, and Ureaplasma urealyticum/parvum.
Sample Required:
Blood, urine, or swab samples from relevant sites (genital, rectal, or throat) based on the specific tests.
Test Time:
Results may vary based on the specific tests performed, typically ranging from a few days to a week.
Test Range Values:
Identification of specific STIs, including Chlamydia, Gonorrhea, Syphilis, Herpes, HIV, Hepatitis B and C, Trichomoniasis, Mycoplasma genitalium, and Ureaplasma urealyticum/parvum.
What is the test?
The STD-11 Panel provides comprehensive screening for multiple sexually transmitted infections (STIs) to assess sexual health comprehensively. It covers a wide range of infections, including bacterial, viral, and parasitic STIs. Testing aids in the early detection and treatment of these infections.
Test Procedure:
Depending on the specific tests included, samples such as blood, urine, or swabs from genital, rectal, or throat areas are collected. Laboratory analysis using various techniques, including PCR and serological assays, is performed to detect the presence of specific STIs.
When to take the test:
The STD-11 Panel is recommended for individuals with symptoms of STIs, recent unprotected sexual activity, or potential exposure to infected partners. It is also suitable for routine screening, especially for sexually active individuals or those at higher risk.
Who should take the test:
Individuals at risk of multiple STIs, including sexually active individuals, those with new or multiple sexual partners, and individuals engaging in unprotected sex, undergo the STD-11 Panel for comprehensive STI screening.
Precautions for exceptional cases (pregnancy, etc.):
Pregnant individuals can undergo the STD-11 Panel if necessary. Seeking individualised advice from a healthcare provider is imperative.
Frequently Asked Questions (FAQs) for STD-11 Panel:
Q1: Is it necessary to be tested for all 11 infections in the STD-11 Panel?
A: The specific tests included in the STD-11 Panel depend on individual risk factors, symptoms, and healthcare provider recommendations. While all 11 infections are covered in the panel, not every individual needs every test. Healthcare providers assess the situation and tailor the testing based on the individual’s needs.
Q2: Can the STD-11 Panel detect recent infections?
A: Yes, the STD-11 Panel includes tests that can detect recent infections, such as Chlamydia, Gonorrhea, HIV, and Syphilis. Early detection and treatment of these infections are crucial for preventing complications and reducing the risk of transmission to others.
Q3: Are all STIs treatable?
A: Many STIs, including Chlamydia, Gonorrhea, Syphilis, and Trichomoniasis, are treatable with appropriate antibiotics. Viral infections like HIV, Herpes, Hepatitis B, and Hepatitis C have no cure, but medications can manage the conditions and reduce complications. Early diagnosis and treatment are essential for managing STIs effectively.
*Please note that specific testing protocols and guidelines may vary based on the latest recommendations from health authorities and regulatory agencies. It is essential to consult healthcare professionals and follow local testing guidelines for accurate and appropriate testing.
